Company profile: Nuevolution
1.1 - Company Overview
Company description
- Provider of small molecule lead discovery services, conducting drug discovery through partner-funded programs and collaborative projects. Utilizes Chemetics, a patent-protected hybrid of wet chemistry and molecular biology enabling fragment-based drug discovery.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nuevolution
Halo Labs
HQ: United States
Website
- Description: Provider of biopharmaceutical quality control tools and particle analysis systems using optics, image processing, and microfluidics. Offerings include Aura+ analyzers; Aura PTx for protein therapy stability; Aura GT for viral vector stability; Aura CL for cell therapy particle characterization; Particle Vue software (21 CFR Part 11); and 0.8 µm black membrane plates.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Halo Labs company profile →
CC Bio
HQ: United Kingdom
Website
- Description: Provider of microbiome-focused therapeutic discovery for diagnosis and treatment. Products include Zeus, a platform to evaluate and optimize therapeutics for precise augmentation of microbial ecology; Athena, a platform developing genetic components for biosensor circuits that sense microbiome diseases; and Dionysus, a program engineering bacterial chassis to sense metabolic changes and record information across human tissues.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CC Bio company profile →
S-Biomedic
HQ: United States
Website
- Description: Provider of skin microbiome therapeutic solutions using targeted modulation-based technology, offering Living Skin Probiotics (Cutibacterium) to aid recovery of a healthy microbiome, Sencyr Microbiome Care for acne-prone skin, CutiNaturalis Probiotic to restore microbiome balance, proprietary Modulation Technology to restore beneficial bacteria, and Living Skin Postbiotics from skin commensals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full S-Biomedic company profile →
Immunologix
HQ: United States
Website
- Description: Provider of antibody-based therapeutics, producing human monoclonal antibodies targeting viral, bacterial, and tumor antigens, as well as human auto antigens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunologix company profile →
Detraxi
HQ: United States
Website
- Description: Provider of proprietary biotechnology solutions addressing blood and organ shortages, including alternatives to whole or derived blood products aimed at eliminating the need for donations; technologies to preserve and regenerate organs outside the body to extend transplant viability; regenerative medicine to engineer organs and reduce reliance on donated tissues; and enhanced diagnostics to better preserve samples and improve test accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Detraxi company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nuevolution
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nuevolution
2.2 - Growth funds investing in similar companies to Nuevolution
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nuevolution
4.2 - Public trading comparable groups for Nuevolution
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →